Radiopharmaceuticals in Nuclear Medical Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals in Nuclear Medical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals in Nuclear Medical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals in Nuclear Medical Overall Market Size
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size: 2021 VS 2027
2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Radiopharmaceuticals in Nuclear Medical Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Radiopharmaceuticals in Nuclear Medical Players in Global Market
3.2 Top Global Radiopharmaceuticals in Nuclear Medical Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals in Nuclear Medical Revenue by Companies
3.4 Global Radiopharmaceuticals in Nuclear Medical Sales by Companies
3.5 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceuticals in Nuclear Medical Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medical Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceuticals in Nuclear Medical Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medical Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceuticals in Nuclear Medical Market Size Markets, 2021 & 2027
4.1.2 Diagnostic Radiopharmaceuticals
4.1.3 Therapy Radiopharmaceuticals
4.1.4 Enriched Stable Isotopes
4.2 By Type - Global Radiopharmaceuticals in Nuclear Medical Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2021
4.2.2 By Type - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2022-2027
4.2.3 By Type - Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share, 2016-2027
4.3 By Type - Global Radiopharmaceuticals in Nuclear Medical Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceuticals in Nuclear Medical Sales, 2016-2021
4.3.2 By Type - Global Radiopharmaceuticals in Nuclear Medical Sales, 2022-2027
4.3.3 By Type - Global Radiopharmaceuticals in Nuclear Medical Sales Market Share, 2016-2027
4.4 By Type - Global Radiopharmaceuticals in Nuclear Medical Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceuticals in Nuclear Medical Market Size, 2021 & 2027
5.1.2 Diagnostic Application
5.1.3 Therapeutic Application
5.1.4 Research
5.1.5 Pharmaceutical
5.1.6 Industrial
5.2 By Application - Global Radiopharmaceuticals in Nuclear Medical Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2021
5.2.2 By Application - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2022-2027
5.2.3 By Application - Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share, 2016-2027
5.3 By Application - Global Radiopharmaceuticals in Nuclear Medical Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceuticals in Nuclear Medical Sales, 2016-2021
5.3.2 By Application - Global Radiopharmaceuticals in Nuclear Medical Sales, 2022-2027
5.3.3 By Application - Global Radiopharmaceuticals in Nuclear Medical Sales Market Share, 2016-2027
5.4 By Application - Global Radiopharmaceuticals in Nuclear Medical Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Radiopharmaceuticals in Nuclear Medical Market Size, 2021 & 2027
6.2 By Region - Global Radiopharmaceuticals in Nuclear Medical Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2021
6.2.2 By Region - Global Radiopharmaceuticals in Nuclear Medical Revenue, 2022-2027
6.2.3 By Region - Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share, 2016-2027
6.3 By Region - Global Radiopharmaceuticals in Nuclear Medical Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceuticals in Nuclear Medical Sales, 2016-2021
6.3.2 By Region - Global Radiopharmaceuticals in Nuclear Medical Sales, 2022-2027
6.3.3 By Region - Global Radiopharmaceuticals in Nuclear Medical Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2027
6.4.2 By Country - North America Radiopharmaceuticals in Nuclear Medical Sales, 2016-2027
6.4.3 US Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.4.4 Canada Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.4.5 Mexico Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2027
6.5.2 By Country - Europe Radiopharmaceuticals in Nuclear Medical Sales, 2016-2027
6.5.3 Germany Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.4 France Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.5 U.K. Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.6 Italy Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.7 Russia Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.8 Nordic Countries Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.5.9 Benelux Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2027
6.6.2 By Region - Asia Radiopharmaceuticals in Nuclear Medical Sales, 2016-2027
6.6.3 China Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.6.4 Japan Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.6.5 South Korea Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.6.6 Southeast Asia Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.6.7 India Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2027
6.7.2 By Country - South America Radiopharmaceuticals in Nuclear Medical Sales, 2016-2027
6.7.3 Brazil Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.7.4 Argentina Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales, 2016-2027
6.8.3 Turkey Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.8.4 Israel Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.8.5 Saudi Arabia Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
6.8.6 UAE Radiopharmaceuticals in Nuclear Medical Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporate Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.1.5 Bracco Imaging Key News
7.2 Cambridge Isotope Laboratories
7.2.1 Cambridge Isotope Laboratories Corporate Summary
7.2.2 Cambridge Isotope Laboratories Business Overview
7.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.2.5 Cambridge Isotope Laboratories Key News
7.3 Cardinal Health
7.3.1 Cardinal Health Corporate Summary
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.3.5 Cardinal Health Key News
7.4 Medtronic
7.4.1 Medtronic Corporate Summary
7.4.2 Medtronic Business Overview
7.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.4.5 Medtronic Key News
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Corporate Summary
7.5.2 Eczacibasi-Monrol Business Overview
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.5.5 Eczacibasi-Monrol Key News
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Corporate Summary
7.6.2 Fujifilm Holdings Corporation Business Overview
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.6.5 Fujifilm Holdings Corporation Key News
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporate Summary
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.4.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Key News
7.8 IBA Group
7.8.1 IBA Group Corporate Summary
7.8.2 IBA Group Business Overview
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.8.5 IBA Group Key News
7.9 Lantheus Medical Imaging
7.9.1 Lantheus Medical Imaging Corporate Summary
7.9.2 Lantheus Medical Imaging Business Overview
7.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.9.5 Lantheus Medical Imaging Key News
7.10 Nordion
7.10.1 Nordion Corporate Summary
7.10.2 Nordion Business Overview
7.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.10.5 Nordion Key News
7.11 Ntp Radioisotopes
7.11.1 Ntp Radioisotopes Corporate Summary
7.11.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Business Overview
7.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.11.5 Ntp Radioisotopes Key News
7.12 Siemens Healthcare
7.12.1 Siemens Healthcare Corporate Summary
7.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Business Overview
7.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.12.5 Siemens Healthcare Key News
7.13 Taiyo Nippon Sanso Corporation
7.13.1 Taiyo Nippon Sanso Corporation Corporate Summary
7.13.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Business Overview
7.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.13.5 Taiyo Nippon Sanso Corporation Key News
7.14 Urenco Limited
7.14.1 Urenco Limited Corporate Summary
7.14.2 Urenco Limited Business Overview
7.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.14.5 Urenco Limited Key News
7.15 Rotem Industries
7.15.1 Rotem Industries Corporate Summary
7.15.2 Rotem Industries Business Overview
7.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Major Product Offerings
7.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales and Revenue in Global (2016-2021)
7.15.5 Rotem Industries Key News
8 Global Radiopharmaceuticals in Nuclear Medical Production Capacity, Analysis
8.1 Global Radiopharmaceuticals in Nuclear Medical Production Capacity, 2016-2027
8.2 Radiopharmaceuticals in Nuclear Medical Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceuticals in Nuclear Medical Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceuticals in Nuclear Medical Supply Chain Analysis
10.1 Radiopharmaceuticals in Nuclear Medical Industry Value Chain
10.2 Radiopharmaceuticals in Nuclear Medical Upstream Market
10.3 Radiopharmaceuticals in Nuclear Medical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceuticals in Nuclear Medical Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Radiopharmaceuticals in Nuclear Medical in Global Market
Table 2. Top Radiopharmaceuticals in Nuclear Medical Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Radiopharmaceuticals in Nuclear Medical Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Companies, 2016-2021
Table 5. Global Radiopharmaceuticals in Nuclear Medical Sales by Companies, (K MT), 2016-2021
Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 9. List of Global Tier 1 Radiopharmaceuticals in Nuclear Medical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceuticals in Nuclear Medical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries